| CNPFX | GFFDX | CNPFX / GFFDX | |
| Total Expense Ratio | 0.84 | 0.87 | 97% |
| Annual Report Gross Expense Ratio | 0.84 | 0.87 | 97% |
| Fund Existence | 23 years | 7 years | - |
| Gain YTD | 16.656 | 11.924 | 140% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 159B | 572M | 27,797% |
| Annual Yield % from dividends | 0.61 | 0.00 | - |
| Returns for 1 year | 11.83 | 13.13 | 90% |
| Returns for 3 years | 47.79 | 83.19 | 57% |
| Returns for 5 years | 28.78 | 16.90 | 170% |
| Returns for 10 years | 99.50 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MQQQ | 176.82 | 1.68 | +0.96% |
| Tradr 2X Long Innovation 100 Monthly ETF | |||
| BBC | 33.79 | 0.04 | +0.12% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| BBSC | 70.77 | -0.01 | -0.02% |
| JPMorgan BetaBuilders US Sml Cp Eq ETF | |||
| BTA | 9.41 | -0.05 | -0.53% |
| Blackrock Long-Term Municipal Advantage Trust | |||
| IDV | 37.34 | -0.28 | -0.74% |
| iShares International Select Div ETF | |||